Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 2 von 25
Clinical immunology (Orlando, Fla.), 2004-12, Vol.113 (3), p.256-260
2004
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Heterozygote AG variant of −596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL)
Ist Teil von
  • Clinical immunology (Orlando, Fla.), 2004-12, Vol.113 (3), p.256-260
Ort / Verlag
San Diego, CA: Elsevier Inc
Erscheinungsjahr
2004
Quelle
Access via ScienceDirect (Elsevier)
Beschreibungen/Notizen
  • The aim of the study was to investigate possible associations of IL-6 gene polymorphisms (−596 A/G and −174 C/G) with cutaneous T-cell lymphoma (CTCL). In the case-control study, genotype distributions and allelic frequencies in two promoter IL-6 gene polymorphisms in the group of 63 Czech patients with CTCL were compared to those of 105 control non-CTCL subjects matched for age and sex. The IL-6 gene polymorphisms were determined by PCR with following restriction analysis. A significant difference of −596 A/G IL-6 genotype distribution was found between the CTCL patients and the controls ( P = 0.002) with almost threefold odds ratio for the heterozygote (AG) genotype in CTCL patients (OR = 2.64, P = 0.002). No significant differences in genotype distribution and/or allelic frequency of functional −174 C/G IL-6 gene polymorphism were observed. The double heterozygote AGCG of both IL-6 promoter polymorphisms was associated with CTCL (OR = 2.24, 95% confidence interval 1.17–4.28, P = 0.01). Thus, the heterozygote variant of −596 A/G promoter IL-6 polymorphism could be considered as a genotype marker for CTCL.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX